Relationship of blood pressure to retinal vessel diameter in type 1 diabetes mellitus

Archives of Ophthalmology

Volumn 128, Issue 2, 2010, Pages 198-205

  Klein, Ronald ^a   Myers, Chelsea E ^a   Klein, Barbara E K ^a   Zinman, Bernard ^b   Gardiner, Robert ^d   Suissa, Samy ^d   Sinaiko, Alan R ^e   Donnelly, Sandra M ^c   Goodyer, Paul ^d   Strand, Trudy ^e   Mauer, Michael ^e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL MALEATE; GLYCOSYLATED HEMOGLOBIN; LOSARTAN POTASSIUM; PLACEBO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTERIOLE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD VESSEL DIAMETER; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EYE; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARALLEL DESIGN; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD VESSEL; SYSTOLIC BLOOD PRESSURE; VENULE;

ADOLESCENT; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIOLES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LOSARTAN; MALE; MIDDLE AGED; RETINAL VESSELS; VENULES;

EID: 76349112948     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.391     Document Type: Article

References (37)

1. Hubbard LD, Brothers RJ, King WN, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology. 1999;106(12):2269-2280.
2. Klein R, Klein BE, Moss SE, et al. Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy, XVIII. Ophthalmology. 2003;110(11):2118-2125.
3. Sharrett AR, Hubbard LD, Cooper LS, et al. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1999;150(3):263-270.
4. Wong TY, Hubbard LD, Klein R, et al. Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol. 2002;86(9):1007-1013.
5. Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P. Impact of current and past blood pressure on retinal arteriolar diameter in an older population. J Hypertens. 2004;22(8):1543-1549.
6. Klein R, Klein BE, Moss SE, Wong TY, Sharrett AR. Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy, XX. Ophthalmology. 2006;113(9):1488-1498.
7. Wong TY, Knudtson MD, Klein BE, Klein R, Hubbard LD. Medication use and retinal vessel diameters. Am J Ophthalmol. 2005;139(2):373-375.
8. Pose-Reino A, Rodriguez-Fernandez M, Hayik B, et al. Regression of alterations in retinal microcirculation following treatment for arterial hypertension. J Clin Hypertens (Greenwich). 2006;8(8):590-595.
9. Dahlöf B, Stenkula S, Hansson L. Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment. Blood Press. 1992;1(1):35-44.
10. Thom S, Stettler C, Stanton A, et al. Differential effects of antihypertensive treatment on the retinal microcirculation: an Anglo-Scandinavian Cardiac Outcomes Trial substudy. Hypertension. 2009;54(2):405-408.
11. Hughes AD, Stanton AV, Jabbar AS, Chapman N, Martinez-Perez ME, McG Thom SA. Effect of antihypertensive treatment on retinal microvascular changes in hypertension. J Hypertens. 2008;26(8):1703-1707.
12. Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women: the Atherosclerosis Risk in Communities Study. JAMA. 2002;287(9):1153-1159.
13. Wong TY, Klein R, Sharrett AR, et al; ARIC Investigators. Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA. 2002; 287(19):2528-2533.
14. Wong TY, Klein R, Sharrett AR, et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke. 2002;33(6):1487-1492.
15. Wong TY, Klein R, Sharrett AR, et al; ARIC Investigators. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA. 2002;288(1):67-74.
16. Wong TY, Klein R, Nieto FJ, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology. 2003;110(5):933-940.
17. Wong TY, Islam FM, Klein R, et al. Retinal vascular caliber, cardiovascular risk factors, and inflammation: the Multi-Ethnic Study of Atherosclerosis (MESA). Invest Ophthalmol Vis Sci. 2006;47(6):2341-2350.
18. Ikram MK, de Jong FJ, Vingerling JR, et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? the Rotterdam Study. Invest Ophthalmol Vis Sci. 2004;45(7):2129-2134.
19. Goto I, Katsuki S, Ikui H, Kimoto K, Mimatsu T. Pathological studies on the intracerebral and retinal arteries in cerebrovascular and noncerebrovascular diseases. Stroke. 1975;6(3):263-269.
20. Carlson EC. Scanning and transmission electron microscopic studies of normal and diabetic acellular glomerular and retinal microvessel basement membranes. Microsc Res Tech. 1994;28(3):165-177.
21. Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med. 2009;361(1):40-51.
22. Mauer M, Zinman B, Gardiner R, et al. ACE-I and ARBs in early diabetic nephropathy. J Renin Angiotensin Aldosterone Syst. 2002;3(4):262-269.
23. Staessen J, Bulpitt CJ, Fagard R, et al. Reference values for ambulatory blood pressure: a population study. J Hypertens Suppl. 1991;9(6):S320-S321.
24. Poggi L, Mallion JM, Renucci JF, et al. Non-invasive ambulatory measurement of arterial pressure: recommendations of the measurement group of the French Society of Arterial Hypertension [in French]. Arch Mal Coeur Vaiss. 1993;86 (8):1137-1142.
25. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology. 1991;98(5)(suppl):786-806.
26. Klein R, Klein BE, Magli YL, et al. An alternative method of grading diabetic retinopathy. Ophthalmology. 1986;93(9):1183-1187.
27. Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, Klein BE. Revised formulas for summarizing retinal vessel diameters. Curr Eye Res. 2003;27(3): 143-149.
28. Danser AH, van den Dorpel MA, Deinum J, et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab. 1989;68(1):160-167.
29. Chaturvedi N. Modulation of the renin-angiotensin system and retinopathy. Heart. 2000;84(suppl 1):i29-i31, discussion i50.
30. Buikema H, Monnink SH, Tio RA, Crijns HJ, de Zeeuw D, van Gilst WH. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure. Br J Pharmacol. 2000;130(8):1999-2007.
31. Rolland PH, Souchet T, Friggi A, et al. Aorta viscoelasticity and arterial histopathology of atherosclerotic pigs treated by angiotensin converting enzyme inhibition. J Hypertens Suppl. 1991;9(6):S178-S179.
32. G-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension. 2000;36(1):103-109.
33. Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide. 2001;5(2): 88-97.
34. Keidar S, Attias J, Coleman R, Wirth K, Scholkens B, Hayek T. Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin. J Cardiovasc Pharmacol. 2000;35(1):64-72.
35. de Nigris F, D'Armiento FP, Somma P, et al. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. Int J Cardiol. 2001;81 (2-3):107-116.
36. KowalaMC,Grove RI, Aberg G. Inhibitors of angiotensin convertingenzymedecrease early atherosclerosis in hyperlipidemic hamsters: fosinopril reduces plasma cholesterolandcaptoprilinhibitsmacrophage- foamcellaccumulationindependentlyofblood pressure and plasma lipids. Atherosclerosis. 1994;108(1):61-72.
37. Klein R, Klein BE, Knudtson MD, Wong TY, Tsai MY. Are inflammatory factors related to retinal vessel caliber? the Beaver Dam Eye Study. Arch Ophthalmol. 2006;124(1):87-94.